These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3928412)

  • 1. [Initial remission period in insulin-dependent diabetes in the young subject].
    Vague P; Vialettes B; Lassmann V; Moulin JP
    Diabete Metab; 1985 Jun; 11(3):181-8. PubMed ID: 3928412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The period of initial remission in insulin-dependent diabetes. Effect of optimized insulin therapy].
    Vague P; Vialettes B; Lassmann V; Moulin JP
    Journ Annu Diabetol Hotel Dieu; 1984; ():73-84. PubMed ID: 6399541
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence of an accelerated B-cell destruction in HLA-Dw3/Dw4 heterozygous children with type 1 (insulin-dependent) diabetes.
    Knip M; Ilonen J; Mustonen A; Akerblom HK
    Diabetologia; 1986 Jun; 29(6):347-51. PubMed ID: 3527834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of insulin-dependent (type I) diabetes mellitus].
    Weber B
    Monatsschr Kinderheilkd; 1985 Jun; 133(6):355-63. PubMed ID: 2931586
    [No Abstract]   [Full Text] [Related]  

  • 5. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
    Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
    Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Lady-like": is there a latent autoimmune diabetes in the young?
    Lohmann T; Nietzschmann U; Kiess W
    Diabetes Care; 2000 Nov; 23(11):1707-8. PubMed ID: 11092301
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained initial remission induced by intensive insulin treatment in type I diabetes. Possible role of the genetic background.
    Vague P; Vialettes B; Lassmann V; Moulin JP; Mercier P
    Acta Diabetol Lat; 1985; 22(4):295-304. PubMed ID: 3914156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes.
    Di Bonito P; De Bellis A; Capaldo B; Turco S; Corigliano G; Pace E; Bizzarro A
    Acta Diabetol; 1996 Sep; 33(3):220-4. PubMed ID: 8904929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus.
    Bonfanti R; Bazzigaluppi E; Calori G; Riva MC; Viscardi M; Bognetti E; Meschi F; Bosi E; Chiumello G; Bonifacio E
    Diabet Med; 1998 Oct; 15(10):844-50. PubMed ID: 9796885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents.
    Böber E; Dündar B; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2001 Apr; 14(4):435-41. PubMed ID: 11327378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural course of remission in IDDM during 1st yr after diagnosis.
    Martin S; Pawlowski B; Greulich B; Ziegler AG; Mandrup-Poulsen T; Mahon J
    Diabetes Care; 1992 Jan; 15(1):66-74. PubMed ID: 1737543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honeymoon period in insulin-dependent diabetes mellitus.
    Heinze E; Thon A
    Pediatrician; 1983-1985; 12(4):208-12. PubMed ID: 6400451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunology in the early stages of type I diabetes.
    Di Mario U; Pozzilli P; Andreani D
    J Endocrinol Invest; 1983 Oct; 6(5):395-400. PubMed ID: 6363509
    [No Abstract]   [Full Text] [Related]  

  • 14. Pittsburgh diabetes mellitus study: studies on the etiology of insulin-dependent diabetes mellitus with special reference to viral infections.
    Drash A; Cavender D; Atchison R; Becker D; Eberhardt M; Laporte R; Kuller L; Orchard T; Rabin B; Wagener D
    Behring Inst Mitt; 1984 Jul; (75):58-72. PubMed ID: 6385955
    [No Abstract]   [Full Text] [Related]  

  • 15. Islet-cell antibodies (ICA-CFICA) and HLA genotypes in 107 IDD patients and their first-degree relatives.
    Deschamps I; Homberg JC; Janssen F; Lemut H; Vexiau P; Hors J
    Hum Immunol; 1984 Jun; 10(2):129-34. PubMed ID: 6376432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antibody response to insulin therapy. A prospective study in HLA-typed insulin-dependent diabetic subjects.
    Asplin CM; Dornan TL; Raghu PK; Hansen JA; Palmer JP
    Diabetes; 1984 Oct; 33(10):966-9. PubMed ID: 6383905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetes mellitus type I, thyroid gland autoimmunity, thyroid gland function and HLA status].
    Kehr S; Gastauer R; Winkler G
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):738-42. PubMed ID: 3906379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoprotection in spontaneous remission of type 1 diabetes: long-term follow-up results.
    Yilmaz MT; Devrim AS; Biyal F; Satman I; Arioğlu E; Dinççag N; Karsidağ K; Ozden I; Gürel N; Sipahioğlu F
    Diabetes Res Clin Pract; 1993 Feb; 19(2):151-62. PubMed ID: 8472630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.
    McFarlane SI; Chaiken RL; Hirsch S; Harrington P; Lebovitz HE; Banerji MA
    Diabet Med; 2001 Jan; 18(1):10-6. PubMed ID: 11168335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between first-phase insulin secretion and age, HLA, islet cell antibody status, and development of type I diabetes in 220 juvenile first-degree relatives of diabetic patients.
    Robert JJ; Deschamps I; Chevenne D; Roger M; Mogenet A; Boitard C
    Diabetes Care; 1991 Aug; 14(8):718-23. PubMed ID: 1954807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.